248 related articles for article (PubMed ID: 15958537)
1. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.
Shinohara ET; Geng L; Tan J; Chen H; Shir Y; Edwards E; Halbrook J; Kesicki EA; Kashishian A; Hallahan DE
Cancer Res; 2005 Jun; 65(12):4987-92. PubMed ID: 15958537
[TBL] [Abstract][Full Text] [Related]
2. A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.
Geng L; Tan J; Himmelfarb E; Schueneman A; Niermann K; Brousal J; Fu A; Cuneo K; Kesicki EA; Treiberg J; Hayflick JS; Hallahan DE
Cancer Res; 2004 Jul; 64(14):4893-9. PubMed ID: 15256460
[TBL] [Abstract][Full Text] [Related]
3. Enhanced susceptibility of irradiated tumor vessels to vascular endothelial growth factor receptor tyrosine kinase inhibition.
Zips D; Eicheler W; Geyer P; Hessel F; Dörfler A; Thames HD; Haberey M; Baumann M
Cancer Res; 2005 Jun; 65(12):5374-9. PubMed ID: 15958586
[TBL] [Abstract][Full Text] [Related]
4. Enhanced radiation damage of tumor vasculature by mTOR inhibitors.
Shinohara ET; Cao C; Niermann K; Mu Y; Zeng F; Hallahan DE; Lu B
Oncogene; 2005 Aug; 24(35):5414-22. PubMed ID: 15940265
[TBL] [Abstract][Full Text] [Related]
5. Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks.
Chernikova SB; Wells RL; Elkind MM
Radiat Res; 1999 Feb; 151(2):159-66. PubMed ID: 9952300
[TBL] [Abstract][Full Text] [Related]
6. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
7. Existence of a threshold-like dose for gamma-ray induction of thymic lymphomas and no susceptibility to radiation-induced solid tumors in SCID mice.
Ishii-Ohba H; Kobayashi S; Nishimura M; Shimada Y; Tsuji H; Sado T; Ogiu T
Mutat Res; 2007 Jun; 619(1-2):124-33. PubMed ID: 17397880
[TBL] [Abstract][Full Text] [Related]
8. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
9. SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization.
Ismail IH; Mårtensson S; Moshinsky D; Rice A; Tang C; Howlett A; McMahon G; Hammarsten O
Oncogene; 2004 Jan; 23(4):873-82. PubMed ID: 14661061
[TBL] [Abstract][Full Text] [Related]
10. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes.
Dittmann K; Virsik-Köpp P; Mayer C; Rave-Fränk M; Rodemann HP
Int J Radiat Biol; 2003 Oct; 79(10):801-8. PubMed ID: 14630539
[TBL] [Abstract][Full Text] [Related]
11. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model.
Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E
Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240
[TBL] [Abstract][Full Text] [Related]
12. SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation.
Cuneo KC; Geng L; Tan J; Brousal J; Shinohara ET; Osusky K; Fu A; Shyr Y; Wu H; Hallahan DE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1197-203. PubMed ID: 16504759
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.
Veuger SJ; Curtin NJ; Richardson CJ; Smith GC; Durkacz BW
Cancer Res; 2003 Sep; 63(18):6008-15. PubMed ID: 14522929
[TBL] [Abstract][Full Text] [Related]
14. Influence of tumor cell and stroma sensitivity on tumor response to radiation.
Ogawa K; Boucher Y; Kashiwagi S; Fukumura D; Chen D; Gerweck LE
Cancer Res; 2007 May; 67(9):4016-21. PubMed ID: 17483312
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy.
Daido S; Yamamoto A; Fujiwara K; Sawaya R; Kondo S; Kondo Y
Cancer Res; 2005 May; 65(10):4368-75. PubMed ID: 15899829
[TBL] [Abstract][Full Text] [Related]
16. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation.
Shin EK; Perryman LE; Meek K
J Immunol; 1997 Apr; 158(8):3565-9. PubMed ID: 9103416
[TBL] [Abstract][Full Text] [Related]
17. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
[TBL] [Abstract][Full Text] [Related]
18. The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature.
Fenton BM; Paoni SF
Cancer Res; 2007 Oct; 67(20):9921-8. PubMed ID: 17942924
[TBL] [Abstract][Full Text] [Related]
19. DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice.
Gurley KE; Vo K; Kemp CJ
Cancer Res; 1998 Jul; 58(14):3111-5. PubMed ID: 9679979
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
